WHO Report Increase In HIV Drug Resistance To Dolutegravir

Emerging Dolutegravir Resistance in Children and Adolescents Living With HIV (...) - Katherine SimonПодробнее

WHO Assurance on Drug Resistance to Key HIV Drug, Dolutegravir; New Trial Shows PromiseПодробнее

Why surveillance of HIV drug resistance is essential?Подробнее

CROI 2024: Dolutegravir resistanceПодробнее

WHO warns of growing resistance to GSK's HIV drugПодробнее

New report on HIV drug resistance Challenges and recommendationsПодробнее

Understanding HIV Drug ResistanceПодробнее

Webinar: Addressing HIV drug resistance to protect the effectiveness of HIV treatmentПодробнее

Dolutegravir: Pros and Cons (Are There Any Cons?)Подробнее

Biktarvy - Bictegravir-Tenofovir alafenamide-EmtricitabineПодробнее

Overview of Newer and Upcoming Antivirals for HIV - Ep. 7Подробнее

DOVATO® (dolutegravir/lamivudine) Mechanism of Action for HIVПодробнее

WHO highlights growing HIV drug resistance to dolutegravir, urges Global Action | UPSC | paper-3Подробнее

New report documents increase in HIV drug resistance to dolutegravirПодробнее